Showing 30 of 3714 posts
Experian delivered 7% organic revenue growth in Q1, with strong B2B trading offsetting weaker North American Consumer Services.
JoshuaJuly 16, 2026
Ramsdens now expects FY26 profit before tax of £32 million-£35 million, supported by gold trading and record pawnbroking demand.
JoshuaJuly 16, 2026
Diploma has upgraded FY26 guidance again, with organic revenue growth now expected at 14% and operating profit growth at around 42%.
JoshuaJuly 16, 2026
Maven Income and Growth VCT 5's NAV slipped, but profitable exits and a fully subscribed offer strengthened its cash position.
JoshuaJuly 15, 2026
GSK has completed its Nuvalent acquisition, gaining three lung cancer assets in a deal carrying an £8 billion equity value.
JoshuaJuly 15, 2026
Supermarket Income REIT will acquire three supermarkets for £118 million, adding inflation-linked rental income at a 6.9% net initial yield.
JoshuaJuly 15, 2026
Zenith Energy's proposed €12 million solar portfolio sale could deliver €7 million of gross profit, but the deal is not yet binding.
JoshuaJuly 15, 2026
SEGRO has signed three Coventry leases covering around 540,000 sq ft, adding £6 million of new rent already included in its first-half total.
JoshuaJuly 15, 2026
Savannah's first 20Mt lithium reserve backs Barroso's 14-year Phase 1 plan, although permitting, funding and execution risks remain.
JoshuaJuly 15, 2026
Thames Water improved profit and pollution performance, but £18.5 billion of net debt and limited funding visibility dominate the outlook.
JoshuaJuly 15, 2026
Gore Street Energy Storage Fund's NAV fell to 74.9p per share, putting the focus firmly on asset sales, cost cuts and portfolio improvements.
JoshuaJuly 15, 2026
Artisanal Spirits kept FY26 expectations unchanged after branded growth and cost control offset weaker first-half trade cask sales.
JoshuaJuly 15, 2026
Audioboom's first-half revenue rose 30% to US$45.7 million, while adjusted EBITDA increased 80% to US$3.2 million.
JoshuaJuly 15, 2026
Barratt Redrow completed 17,667 homes in FY26 and plans to return £400 million, mainly through share buybacks, despite a tough market.
JoshuaJuly 15, 2026
Eco Animal Health delivered 10% revenue growth, a higher gross margin and its first vaccine launch, although China remains a near-term concern.
JoshuaJuly 15, 2026
CelLBxHealth's Q2 revenue doubled to £0.4 million, but lower first-half revenue and a £2.9 million cash balance keep funding risk central to the investment case.
JoshuaJuly 15, 2026
B&M's Q1 revenue rose 2%, with strong growth in France and Heron Foods offsetting weaker like-for-like sales at its core UK business.
JoshuaJuly 15, 2026
James Cropper beat Board expectations in FY26, returning to profit and cutting net debt, although Advanced Materials faces a near-term slowdown.
JoshuaJuly 15, 2026
Beeks expects FY26 revenue of £40.0 million and underlying EBITDA of £16.0 million, supported by recurring revenue growth and new deployments.
JoshuaJuly 15, 2026
Dr. Martens kept FY27 guidance unchanged, with continued US growth and encouraging wholesale trading, but the brief AGM update included no new financial figures.
JoshuaJuly 15, 2026
Galliford Try expects a sixth year of revenue, profit and cash growth, supported by a £4.3 billion order book and £258.8 million cash.
JoshuaJuly 15, 2026
Bank Muscat's first-half net profit rose 9.3% to RO 137.49 million, supported by stronger non-interest income and lower impairments.
JoshuaJuly 15, 2026
Zegona delivered a third quarter of revenue growth as customer numbers increased, debt fell and refinancing lowered expected interest costs.
JoshuaJuly 15, 2026
Cohort delivered record revenue and profit, with strong order cover supporting growth expectations despite weaker cash conversion.
JoshuaJuly 15, 2026
Bloomsbury remains confident of meeting full-year expectations as new titles, academic growth and AI licensing support its outlook.
JoshuaJuly 15, 2026
Hunting has retained its 2026 guidance, backed by a larger order book and strong demand across its Subsea and Perforating Systems businesses.
JoshuaJuly 15, 2026
Volex will pay up to $89.4 million for full control of Kepler SignalTek, a growing manufacturer of patient-connected medical products.
JoshuaJuly 14, 2026
Watches of Switzerland reports record FY26 revenue, strong US growth and improved cash flow, while margins remain the key investor concern.
JoshuaJuly 14, 2026
Rank Group expects full-year underlying operating profit of at least £76 million, comfortably ahead of consensus, as digital growth and tighter cost control offset higher gaming taxes.
JoshuaJuly 14, 2026
The perfect buying opportunity is obvious only in hindsight. Long-term investors may be better served by building a repeatable investment process than waiting indefinitely for a dramatic market fall.
JoshuaJuly 13, 2026